Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy

OBJECTIVES: We previously described adoptive immunotherapy (AIT) with cytotoxic T lymphocytes (CTLs) stimulated by the mucin 1 (MUC1)–expressing human pancreatic cancer cell line YPK-1 (MUC1-CTLs) and demonstrated that MUC1-CTLs might prevent liver metastasis. In the present study, we combined gemci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pancreas
Main Authors: Matsui, Hiroto, Hazama, Shoichi, Sakamoto, Kazuhiko, Shindo, Yoshitaro, Kanekiyo, Shinsuke, Nakashima, Masao, Matsukuma, Satoshi, Tokuhisa, Yoshihiro, Iida, Michihisa, Suzuki, Nobuaki, Yoshimura, Kiyoshi, Takeda, Shigeru, Ueno, Tomio, Yoshino, Shigefumi, Oka, Masaaki, Nagano, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5555975/
https://ncbi.nlm.nih.gov/pubmed/28697053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000000880
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados